Merline Saintil, identified as a Director of Rocket Lab USA Inc. (RKLB), reported an open-market sale of 18,126 shares of common stock on March 6, 2026, at a weighted average price of $75.0398 per share (ranging from $75.0000 to $75.0950). Following the transaction, she beneficially owns 261,903 shares directly, with no indirect ownership or derivative securities reported in the filing. The Form 4 does not indicate that the transaction was pursuant to a Rule 10b5-1 trading plan, suggesting it was discretionary. The sale represents approximately 6.5% of her pre-transaction direct holdings (261,903 + 18,126 = 280,029 shares) and has a total value of about $1.36 million. No historical trading patterns or context relative to earnings, announcements, or 52-week price ranges are provided in the filing, but the timing is recent ahead of the March 10, 2026 analysis date.

This discretionary sale exceeding $1M by a director signals moderate bearish sentiment or liquidity needs, though the modest percentage of holdings sold (6.5%) limits the negative implication on insider confidence.